|4Feb 23, 5:00 PM ET

Harsh Michael 4

4 · ENDRA Life Sciences Inc. · Filed Feb 23, 2024

Insider Transaction Report

Form 4
Period: 2024-01-02
Transactions
  • Award

    Stock Options

    2024-01-02+600600 total
    Exercise: $1.59Exp: 2034-01-02Common Stock (600 underlying)
Footnotes (2)
  • [F1]Represents a stock option award granted on January 2, 2024 pursuant to the Issuer's Non-Employee Director Compensation Policy.
  • [F2]This stock option award becomes exercisable in three equal annual installments beginning January 2, 2025.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION